SALK INSTITUTE FOR BIOLOGICAL STUDIES

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10567
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 99157
 
  
 
C07K PEPTIDES 7861
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3293
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 28178
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2772
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1584
 
  
 
A01H NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES 12116
 
  
 
C07D HETEROCYCLIC COMPOUNDS 12150
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 887

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0057,554 FIBROBLAST GROWTH FACTOR (FGF) 1 MUTANTS AND METHODS OF USE TO REDUCE BLOOD GLUCOSEOct 16, 17Mar 01, 18[A61K, C07K]
2018/0050,087 METHODS OF TREATING LIPODYSTROPHY USING FGF-1 COMPOUNDSOct 06, 17Feb 22, 18[A61K]
2018/0044,642 REPROGRAMMING PROGENITOR COMPOSITIONS AND METHODS OF USE THEREFOREFeb 26, 16Feb 15, 18[C12N]
2018/0015,057 ERR ALPHA AND ERR GAMMA ARE ESSENTIAL COORDINATORS OF CARDIAC METABOLISM AND FUNCTIONSep 19, 17Jan 18, 18[A61K]
2018/0000,768 INTESTINAL FXR AGONISM ENHANCES GLP-1 SIGNALING TO RESTORE PANCREATIC BETA CELL FUNCTIONSSep 06, 17Jan 04, 18[A61K]
2017/0355,739 FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS OF USE TO REDUCE BLOOD GLUCOSEAug 21, 17Dec 14, 17[C07K]
2017/0355,740 METHODS OF USING FIBROBLAST GROWTH FACTOR (FGF) 1 WITH MUTATION IN THE HEPARIN BINDING DOMAIN AND METHODS TO REDUCE BLOOD GLUCOSEAug 21, 17Dec 14, 17[A61K, C12Q, C12N, C07K]
2017/0291,931 FGF2 TRUNCATIONS AND MUTANTS AND USES THEREOFJun 08, 17Oct 12, 17[C07K]
2017/0283,777 MAMMALIAN CHIMERIC COMPLEMENTATIONMar 23, 17Oct 05, 17[C12N]
2017/0246,236 METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDSDec 12, 16Aug 31, 17[A61K, B82Y]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9913866 Selective cell targeting using adenovirus and chemical dimersSep 12, 14Mar 13, 18[A61K, C12N]
9895381 Vitamin D receptor agonists to treat diseases involving CXCL12 activityDec 04, 15Feb 20, 18[A61K]
9885090 Adenoviral tumor diagnosticsSep 12, 14Feb 06, 18[A61K, C12Q, C12N, G01N, C07K]
9886493 Systems and methods for sensory and cognitive profilingSep 27, 13Feb 06, 18[A61B, G06F]
9872866 Vitamin D receptor/SMAD genomic circuit gates fibrotic responseOct 23, 15Jan 23, 18[A61K, G01N]
9850319 Generation and use of polyclonal and monoclonal antibodies specific for 3-phosphohistidineJul 01, 15Dec 26, 17[G01N, C07K]
9808508 Methods for treating metabolic disorders using FGFAug 18, 16Nov 07, 17[A61K]
9744164 Neuroprotective polyphenol analogsFeb 26, 16Aug 29, 17[A61K, C07D, C07C]
9696297 Method for preparing an X chromosome inactivated female human neural cellDec 23, 10Jul 04, 17[C12N, G01N]
9546379 Compositions and methods for treating type 1 and type 2 diabetes and related disordersJul 07, 15Jan 17, 17[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0305,894 PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOFAbandonedOct 07, 15Oct 26, 17[C07D]
2017/0189,485 MODULATION OF ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) AND USES THEREFORAbandonedJan 17, 17Jul 06, 17[A61K]
2017/0157,212 CDK MODULATORS AND METHODS FOR THE TREATMENT OF CANCERAbandonedDec 02, 16Jun 08, 17[A61K, C07K]
2016/0101,086 METHODS OF TREATING MUSCULAR DYSTROPHYAbandonedDec 17, 15Apr 14, 16[A61K, G01N]
2016/0068,863 METHODS FOR HEART REGENERATIONAbandonedNov 19, 15Mar 10, 16[C12N]
2016/0033,516 USE OF POLYCLONAL AND MONOCLONAL ANTIBODIES SPECIFIC FOR 3-PHOSPHOHISTIDINEAbandonedJul 01, 15Feb 04, 16[G01N]
2015/0258,052 METHODS OF USING FEXARAMINE AND AGENTS THAT INCREASE SYMPATHETIC NERVOUS SYSTEM ACTIVITY TO PROMOTE BROWNING OF WHITE ADIPOSE TISSUEAbandonedMar 13, 15Sep 17, 15[A61K]
2015/0167,014 MODULATION OF PLANT GROWTH BY VAS1 MUTATIONAbandonedDec 04, 14Jun 18, 15[C12N]
2015/0164,800 REGULATING THE INTERACTION BETWEEN TAM LIGANDS AND LIPID MEMBRANES WITH EXPOSED PHOSPHATIDYL SERINEAbandonedJul 23, 13Jun 18, 15[A61K, C12Q]
2015/0119,315 MODULATION OF ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) AND USES THEREFORAbandonedJan 15, 15Apr 30, 15[A61K]
2015/0065,395 COMPOSITIONS AND METHODS FOR ANALYZING HISTIDINE PHOSPHORYLATIONAbandonedMar 13, 13Mar 05, 15[C07K]
2015/0010,932 METHODS FOR ASSAYING PROTEIN-PROTEIN INTERACTIONSAbandonedJul 01, 14Jan 08, 15[C12Q]
2015/0007,362 REGULATING THE ETHYLENE RESPONSE OF A PLANT BY MODULATION OF F-BOX PROTEINSAbandonedNov 27, 13Jan 01, 15[C12N]
2014/0356,854 METHODS AND COMPOSITIONS RELATING TO MEVALONATE PHOSPHATE DECARBOXYLASEAbandonedJun 04, 14Dec 04, 14[C12Q, C12P]
2014/0314,788 MODULATION OF HISTONE DEACETYLASES FOR THE TREATMENT OF METABOLIC DISEASE, METHODS AND COMPOSITIONS RELATED THERETOAbandonedApr 11, 11Oct 23, 14[C12N, G01N, C07K]
2014/0196,170 ETHYLENE GAS SIGNALING IN PLANTSAbandonedAug 30, 13Jul 10, 14[C12N]
2014/0186,308 COMPOSITIONS FOR DIRECTING ADIPOSE-DERIVED STEM CELLS TO A CHONDROGENIC DIFFERENTIATION AND METHODS OF USE THEREFORAbandonedDec 10, 13Jul 03, 14[A61K]
2014/0186,328 NEUROPROTECTIVE POLYPHENOL ANALOGSAbandonedFeb 05, 14Jul 03, 14[A61K, C07D, C07C]
2014/0186,329 POLYPHENOL ANALOGS TO TREAT ISCHEMIAAbandonedFeb 06, 14Jul 03, 14[A61K, C07D, C07C]
2014/0162,366 GENERATION OF VASCULAR PROGENITOR CELLSAbandonedSep 03, 13Jun 12, 14[C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.